What Is VolitionRX Limited (VNRX) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, VolitionRX Limited's intrinsic value is estimated at a composite fair value of $0.94. Trading at $1.28, the stock is approaching fair value or slight overvaluation (implied return of -26.3%), as 6 of 9 models suggest limited further upside. Notably, ML-RIV sees the most upside at +113.5% (fair value: $2.73), while Sentiment SOTP is the most conservative at -97.6% ($0.03). The spread between these extremes — +211.1% — reveals how different analytical frameworks can reach starkly different conclusions.
What Do the Models Say About VNRX?
9 of 13 models are currently active for VNRX. Of these, 3 models suggest upside while 6 models suggest overvaluation. The Bayesian DCF estimates VNRX's intrinsic value at $0.32, implying -75.0% downside from the current price. See which stocks rank higher →
How Does VNRX Rank in In Vitro & In Vivo Diagnostic Substances?
Among 17 In Vitro & In Vivo Diagnostic Substances stocks, VNRX ranks #8 by Quality of Company score. CirclFi's QOC score of 6.1/10 evaluates 32 fundamental signals. A score of 6.1 indicates above-average quality.
VolitionRX Limited operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.
Is VNRX a Value Trap?
CirclFi's Value Trap algorithm assigns VNRX a score of 18/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
9 of 13 models are active for VolitionRX Limited. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Deep Alpha Valuation Engine, VolitionRX Limited scores 6.1 out of 10 on our 32-signal quality assessment, a solid rating that maintains reasonable quality metrics with some areas for improvement. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.
The gap between the most bullish and bearish model spans +211.1% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every VNRX valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across VNRX's 9 active models, average confidence is 16%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad